Loading…
Reported covered position: Staffer, Rep. Kathy Castor (Jan. 07 - Feb. 11); Intern/Fellow, Rep. Barbara Lee (2006); Intern, Rep. Danny Davis (2004).
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Puppy Protection Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including H.R. 3112/S. 1538 - Better CARE for Animals Act of 2025 and H.R. 2253 - Puppy Protection Act of 2025.
Puppy Protection Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including animal testing and research, the Better CARE for Animals Act (H.R. 3112/S. 1538) and the Puppy Protection Act (H.R. 2253).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TRANSMEDICS GROUP, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to organ transplantation and the organ transplantation system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Source: Senate LDA
| TRANSMEDICS GROUP, INC. |
| 4 |
| 2026 |
| ALLIANCE FOR AGING RESEARCH | 3 | 2024–2025 |
| BAMBOO HEALTH | 3 | 2025 |
| HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) | 3 | 2025–2026 |
| CHATTEM, INC. DBA OPELLA | 2 | 2025 |
| GLOBAL MEDICAL RESPONSE, INC. | 2 | 2025–2026 |
| HEALTHCARE DISTRIBUTION ALLIANCE | 2 | 2026 |
| QNOVIA, INC. | 2 | 2025 |
| CELLDEX THERAPEUTICS, INC. | 1 | 2025 |
| INTERNATIONAL FLAVORS & FRAGRANCES | 1 | 2026 |
| SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) | 1 | 2025 |
| STANFORD UNIVERSITY | 1 | 2025 |
Better CARE for Animals Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including H.R. 3112/S. 1538 - Better CARE for Animals Act of 2025 and H.R. 2253 - Puppy Protection Act of 2025.
Better CARE for Animals Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including animal testing and research, the Better CARE for Animals Act (H.R. 3112/S. 1538) and the Puppy Protection Act (H.R. 2253).
Better CARE for Animals Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including animal testing and research, the Better CARE for Animals Act (H.R. 3112/S. 1538) and the Puppy Protection Act (H.R. 2253).
Better CARE for Animals Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including H.R. 3112/S. 1538 - Better CARE for Animals Act of 2025 and H.R. 2253 - Puppy Protection Act of 2025.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; Issues related to H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; SUPPORT Act reauthorization proposals, including H.R. 2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; Issues related to H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Lake Winnibigoshish Land Exchange Act of 2024
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare including H.R. 1657 - Humane Cosmetics Act of 2025 and H.R. 5041 / S. 2555 - Better CARE for Animals Act of 2023 (118th Congress).
Better CARE for Animals Act of 2023
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare including H.R. 1657 - Humane Cosmetics Act of 2025 and H.R. 5041 / S. 2555 - Better CARE for Animals Act of 2023 (118th Congress).
Better CARE for Animals Act of 2023
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare including H.R. 1657 - Humane Cosmetics Act of 2025 and H.R. 5041 / S. 2555 - Better CARE for Animals Act of 2023 (118th Congress).
Issues related to distributor-supported service models and related policy, including pharmacy services administrative organizations and management services organizations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL MEDICAL RESPONSE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to Medicaid reimbursement for ground ambulance.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to hospital reimbursement, including sequestration; Issues related to prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; Issues related to 1115 Medicaid Waiver; Issues related to health care workforce; Issues related to maternal health; Issues related to freestanding ERs; Issues related to Medicaid coverage and enrollees and hospital reimbursement.
Issues related to Medicaid; Issues related to hospital reimbursement; Issues related to Children's Hospital GME; Issues related to Disproportionate Share Hospital (DSH) payments; Issues related to site-neutral payment; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to health care workforce; Issues related to hospital reimbursement, rural health, and impacts to low-income populations; Issues related to ACA premium assistance; Issues related to hospital reimbursement and impacts to low-income populations; Issues related to hospital reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UOFL HEALTH, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to patient rehabilitation and research.
Issues related to Medicaid and hospital funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to military health and research; Issues related to cybersecurity; Issues related to defense innovation for Fiscal Year 2027.
Issues related to funding for university research opportunities for Fiscal Year 2027 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to animal welfare, including animal testing and research, the Better CARE for Animals Act (H.R. 3112/S. 1538) and the Puppy Protection Act (H.R. 2253).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to Medicare Advantage compensation and agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · RR
Issues related to distributor-supported service models and related policy.
UOFL HEALTH, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to patient rehabilitation and research.
Filing targets: SENATE
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to military health and research; Issues related to cybersecurity; Issues related to defense innovation for Fiscal Year 2027.
Issues related to funding for university research opportunities through Fiscal Year 2026 and Fiscal Year 2027 appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to Medicare Advantage compensation and agent and broker policies; Issues related to MedPAC nominations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRANSMEDICS GROUP, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to organ transplantation and the organ transplantation system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to hospital reimbursement, including sequestration; Issues related to prescription drug pricing, surprise billing, telehealth, 1115 Medicaid Waiver, the health care workforce, maternal health, freestanding ERs; Issues related to Medicaid coverage and enrollees and hospital reimbursement.
Issues related to Medicaid; hospital reimbursement, Children's Hospital Graduate Medical Education, Disproportionate Share Hospital (DSH) payments, site-neutral payment; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to the health care workforce; Issues related to hospital reimbursement, rural health, and impacts to low-income populations; Issues related to ACA premium assistance.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to animal welfare, including H.R. 3112/S. 1538 - Better CARE for Animals Act of 2025 and H.R. 2253 - Puppy Protection Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERNATIONAL FLAVORS & FRAGRANCES via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · RR
Issues related to trade and tariffs; Issues related to food ingredient safety reform.
Issues related to trade and tariffs; Issues related to food ingredient safety reform.
TRANSMEDICS GROUP, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to organ transplantation and the organ transplantation system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to the National Defense Authorization Act (P.L. 119-60); Issues related to the U.S. Family Health Plan Program.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to hospital reimbursement, including sequestration; Issues related to prescription drug pricing and surprise billing; Issues related to telehealth; Issues related to 1115 Medicaid Waivers; Issues related to maternal health, freestanding ERs, and the health care workforce; Issues related to Medicaid coverage and enrollees; Issues related to hospital reimbursement.
UOFL HEALTH, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to Medicaid and hospital funding.
Issues related to Medicaid funding and reimbursement rates for hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to funding for university research opportunities through Fiscal Year 2026 and Fiscal Year 2027 appropriations.
Issues related to military health and research; Issues related to cybersecurity; Issues related to defense innovation for Fiscal Year 2026 and Fiscal Year 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to Medicare Advantage compensation and agent and broker policies; Issues related to MedPAC nominations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRANSMEDICS GROUP, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · RR
Issues related to updates to the National Organ Transplant Act (NOTA) of 1984 (P.L. 98-507).
UOFL HEALTH, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Medicaid and hospital funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to funding for university research opportunities through Fiscal Year 2026 federal appropriations.
Issues related to military health and research; Issues related to cybersecurity; Issues related to defense innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Medicaid, hospital reimbursement, Childrens Hospital GME, Disproportionate Share Hospital payments, and site-neutral payments; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to the health care workforce.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to hospital reimbursement, including sequestration; Issues related to prescription drug pricing and surprise billing; Issues related to 1115 Medicaid Waivers; Issues related to maternal health, freestanding ERs, and the health care workforce; Issues related to Medicaid coverage and enrollees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
UOFL HEALTH, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Medicaid and hospital funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF LOUISVILLE via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to funding for university research opportunities through Fiscal Year 2026 federal appropriations.
Issues related to military health and research; Issues related to cybersecurity; Issues related to defense innovation.
Issues related to Medicaid; Issues related NIH funding; Issues related to regional biocontainment laboratories; Issues related to precision medicine.
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL MEDICAL RESPONSE, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · RA
Issues related to reimbursement rates.
UOFL HEALTH, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Medicaid funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues regarding smoking cessation; Issues regarding FY26 appropriations bill reports for Labor-HHS and Ag-FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to artificial intelligence, medical devices and Medicare beneficiaries.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; Issues related to H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to utilization management and changes to Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to Medicare and provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES
UOFL HEALTH, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to Medicaid funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to animal welfare including H.R. 1657 - Humane Cosmetics Act of 2025 and H.R. 5041 / S. 2555 - Better CARE for Animals Act of 2023 (118th Congress).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues regarding smoking cessation; FY26 appropriations bill reports for Labor-HHS and Ag-FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHATTEM, INC. DBA OPELLA via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to behavioral health services, prescription drug monitoring programs, care coordination and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; SUPPORT Act reauthorization proposals, including H.R. 2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues pertaining to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to utilization management and changes to Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE US HEALTHCARE LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · RR
Medicare billing for remote patient monitoring and general support for sepsis device breakthrough designation.
Medicare billing for remote patient monitoring and general support for sepsis device breakthrough designation.
STANFORD UNIVERSITY via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · RR
Issues related to higher education.
CELLDEX THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · RR
Issues related to biotechnology policy.
CHATTEM, INC. DBA OPELLA via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · RR
Issues related to non-prescription drug and dietary supplement policy.
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues pertaining to Medicare Advantage compensation, agent, and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to utilization management and changes to Medicare Part D.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Medicaid, hospital reimbursement, Childrens Hospital GME, Disproportionate Share Hospital payments, and site-neutral payments; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to the health care workforce; Issues related to hospital reimbursement, rural health, and impact to low-income populations; Issues related to ACA premium assistance.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Issues related to flash flood preparedness.
Issues related to environmental research involving Vieques.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE